Divisive F.D.A. Vaccine Regulator Is Resigning
The New York Times
Dr. Vinay Prasad drew criticism for overriding career scientists and rejecting drugs by companies seeking agency approval.
Dr. Vinay Prasad drew criticism for overriding career scientists and rejecting drugs by companies seeking agency approval.
One of Us, run by Denmark’s health ministry, works with people with mental health conditions to share their stories in schools, hospitals and police stations, helping turn fear into understanding.
In an attempt to understand our own fascination with the shiny minerals, researchers gave some to chimps.
As the midterm elections approach, the health secretary is focusing on “real food.” Anger is rising among some of his supporters.
Research shows that a phenomenon called St. Elmo’s Fire, which occurs during thunderstorms, may be much more common than previously understood.
Citing rising costs and shortfalls in federal support, about 20 states are toughening eligibility requirements for patients in drug assistance programs.
Palmer Luckey, who founded the defense tech start-up Anduril, has become the It Guy as President Trump aims to modernize the U.S. military with autonomous weapons.
A “back to basics” approach resembles the Apollo program of the 1960s, with more missions launching more often. NASA officials said that it would be safer and faster.
Jeffrey Epstein joined Mr. Cavett’s wife in an effort to create a PBS documentary on the talk-show legend. But then the producers did a background check on the financier.
The Trump administration is proposing Obamacare plans that it says will lower health insurance premiums. But critics warn they would make care unaffordable.
Most people alive today carry fragments of Neanderthal DNA in their genome. Now scientists are gaining a more intimate understanding of the ancient encounters that put it there.
In a draft of his memoir, Changpeng Zhao, the founder of Binance, laid out the secret negotiations that led to his imprisonment and a run-in with ICE.